Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

In situ detection of SOCS and cytokine expression in the uterine cervix from HIV/HPV coinfected women.

Authors: Nicol, AF  Nuovo, GJ  Wang, Y  Grinsztejn, B  Tristao, A  Russomano, F  Perez, MA  Lapa e Silva, JR  Fernandes, AT  Gage, JR  Martinez-Maza, O  Bonecini-Almeida, MG 
Citation: Nicol AF, etal., Exp Mol Pathol. 2006 Aug;81(1):42-7.
Pubmed: (View Article at PubMed) PMID:16878360

The purpose of this study was to look for associations between a newly described class of suppressors of cytokine signaling (SSI/SOCS) and cytokine expression in the uterine cervix from HIV/HPV coinfected women. We examined the pro-inflammatory cytokines TNF-alpha and IL-6 since their expressions are linked and responsible for many aspects of both localized and systemic inflammatory responses. Further, expression of SSI/SOCS has been implicated in the negative feedback regulation of cytokine receptor signaling. PCR-amplified HIV-1 cDNA was noted mainly in the stroma, showing a perivascular distribution, and most of the infected cells colabeled with the macrophage marker CD68. The distribution of IL-6 and TNF-alpha was in the same area to HIV-1 and much greater than normal cervices from women with no evidence of viral infection. SOCS/SSI-1 and -3 mRNA positive cells in the uterine cervix were commonly detected in these noninfected cervical tissues; however, very few cells that contained SOCS were evident in areas where HIV-1, TNF-alpha, and IL-6 expressing cells were found. This suggests that viral-related suppression of SOCS/SSI-1-3 expression may be a factor in the marked local enhancement of TNF-alpha and IL-6 production which, in turn, may help facilitate viral spread; however, further studies should be done in order to elucidate the exact mechanisms of SOCS in the cervix.


Disease Annotations
Objects Annotated

Additional Information

RGD Object Information
RGD ID: 2298904
Created: 2008-07-31
Species: All species
Last Modified: 2008-07-31
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.